Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis

Data de publicació: Data Ahead of Print:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Ortiz-Masiá D
  • Macias-Ceja DC
  • Coll S
  • Gisbert-Ferrándiz L
  • Bauset C
  • Ortega M
  • Heras-Morán B
  • Esplugues JV
  • Calatayud S
  • Barrachina MD

Grups d'Investigació

Abstract

Background and aims: The stiffening of the extracellular matrix, and changes in its cellular and molecular composition, have been reported in the pathogenesis of fibrosis. We analyze the mechanisms that perpetuate ileal fibrosis in surgical resections of complicated Crohn's disease patients.Methods: Ileal resections were obtained from affected and non-affected tissue of stenotic or penetrating Crohn's disease behavior. Ilea from non-IBD patients were used as control tissue. All samples underwent RNA sequencing. Human small intestinal fibroblasts were treated for 48 h with IL-1 beta, TFG beta 1, PDGFB or TNF-alpha. Resistance to apoptosis was analysed by RT-PCR, western blot and immunohistochemistry in ileal tissue and by RT-PCR and FACS in cultured cells.Results: Growth factor-driven signaling pathways and increased RAS GTPase activity were up-regulated in affected ilea in which we found expression of both the antiapoptotic molecule MCL1 and the transcription factor ETS1 in submucosal fibroblasts, and a senescence-associated secretory phenotype. In cultured intestinal fibro-blasts, PDGFB induced an ETS1-mediated resistance to apoptosis that was associated with the induction of both of TGFB1 and IL1B, a cytokine that replicated the expression of SASP detected in ileal tissue. ETS1 drove fibroblast polarization between inflammatory and fibrogenic phenotypes in IL1 beta-treated cells. Conclusions: Our data show resistance to apoptosis in complicated ileal CD, and demonstrate that PDGFB induce an ETS1-mediated resistance to apoptosis associated with an inflammatory and fibrogenic pattern of expression in intestinal fibroblasts. Results point to PDGFRB, IL1R1 or MCL1 as potential targets against ileal fibrosis.

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Dades de la publicació

ISSN/ISSNe:
0925-4439, 0006-3002

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE  ELSEVIER SCIENCE BV

Tipus:
Article
Pàgines:
166966-166966
PubMed:
37995775
Factor d'Impacte:
1,415 SCImago
Quartil:
Q1 SCImago

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • Fibrosis; Crohn's disease; Fibroblasts; Apoptosis; Senescence -associated secretory phenotype

Projectes associats

ESTUDIO DE FASE 4, ALEATORIZADO, MULTICÉNTRICO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE ADALIMUMAB UTILIZADO JUNTO CON CIRUGÍA EN SUJETOS CON HIDRADENITIS SUPURATIVA MODERADA O GRAVE.

Investigador Principal: ANTONIO MARTORELL CALATAYUD

M15-574 . 2017

ENSAYO CLÍNICO, ALEATORIZADO, CONTROLADO PARA COMPARAR LA EFICACIA DEL ADHESIVO TISULAR FLEXIBLE (ADHFLEX®) FRENTE A LAS TÉCNICAS DE SUTURA CONVENCIONAL EN EL CIERRE DE INCISIONES DE CIRUGÍA ABDOMINAL.

Investigador Principal: RAFAEL ALÓS COMPANY

ADHBIO-001-012

ESTUDIO DE SEGURIDAD POSAUTORIZACIÓN PARA EVALUAR LA SEGURIDAD Y LA EFICACIA A LARGO PLAZO DE LA ADMINISTRACIÓN REPETIDA DE DARVADSTROCEL EN PACIENTES CON ENFERMEDAD DE CROHN Y FÍSTULAS PERIANALES COMPLEJAS (ASPIRE).

Investigador Principal: ADELA BATISTA DOMENECH

ALOFISEL-4001 . 2020

ESTUDIO MULTICÉNTRICO PROSPECTIVO, CONTROLADO, ALEATORIZADO DE NO INFERIORIDAD SOBRE EL MANEJO DE LA SONDA VESICAL EN CIRUGÍA DE COLON.

Investigador Principal: MÓNICA MILLÁN SCHEIDING

CR-VESICATH . 2021

FRAilty incidence in surGIcal European patients (FRAGILE) European prospective cohort study of the prevalence of frailty in surgical patients.

Investigador Principal: VIRGINIA MORENO BLANCO

FRAGILE . 2022

Ensayo clínico en fase IIA para evaluar la seguridad y eficacia del tratamiento con células troncales alogénicas mesenquimales derivadas de la grasa en pacientes con estenosis inflamatoria única en el contexto de la Enfermedad de Crohn.

Investigador Principal: MÓNICA MILLÁN SCHEIDING

FJD-MEIC-21-01 . 2023

Estudio comparativo prospectivo multicéntrico aleatorizado del tratamiento de la estenosis de novo en la enfermedad de crohn: tratamiento endoscópico (dilatación con balón / prótesis metálica autoexpandible) vs resección quirúrgica (estudio ENDOCIR).

Investigador Principal: ELENA CERRILLO BATALLER

ESTUDIO ENDOCIR . 2023

An audit on fertility and pregnancy after surgery for IBD Fertile-IBD.

Investigador Principal: HANNA BARBARA CHOLEWA

Fertile-IBD . 2023

HEMO-FISSQoL - Traducción validada al español de un instrumento de medida de la calidad de vida en pacientes con patología hemorroidal y fisura anal.

Investigador Principal: HANNA BARBARA CHOLEWA

HEMO-FISSQoL . 2023

Resultados oncológicos a largo plazo del adenocarcinoma de recto pT1, N0, M0 tratado mediante cirugía endoscópica transanal (TES): Estudio multicéntrico observacional.

Investigador Principal: CARMEN GUTIÉRREZ SÁNCHEZ

TAUTEM 0T1 . 2023

Compartir la publicació